- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Crackdown on 'Mephentermine Sulphate Injection' abuse in Gyms: Stocks seized in Telangana during joint operation
Telangana: Drugs Control Administration,Telangana, in a joint operation with the Telangana Anti-Narcotics Bureau (TGANB), seized illegally stocked and sold cardiac stimulant drugs, Termin Injections and Termiva Injections (Mephentermine Sulphate Injections), from Bariga Akash in Manikonda Jagir, Ranga Reddy District.
Based on credible information, the raid was conducted on 18th January at an unlicensed premise.
During the raid, officials detected stocks of a cardiac stimulant drug, 'Mephentermine Sulphate Injection,' illegally stocked and sold to gym-goers for abuse in bodybuilding. The said injections are being supplied for abuse by Bariga Akash.
Mephentermine Sulphate Injection is a cardiac stimulant primarily used to normalize decreased blood pressure (hypotension) that may arise from administering anesthesia in spinal procedures during surgery. It is employed to elevate blood pressure in cases of hypotensive (low blood pressure) states. This medication induces increased release of noradrenaline, thereby enhancing cardiac output. By augmenting the pumping capacity of the heart and constricting blood vessels, it rapidly raises blood pressure. It's crucial to note that only a doctor should determine the appropriate dose and duration of this medicine for each individual.
However, Mephentermine Sulphate Injection, with its cardiac stimulatory action, is being misused to enhance endurance in bodybuilders. Certain gyms are illegally selling Mephentermine Injection to gym-goers who misuse it to improve physical performance in competitive sports or bodybuilding.
Abuse of Mephentermine Sulphate Injections can result in various adverse effects, including psychosis, cardiovascular disorders, and the development of tolerance and dependence over time.
During the raid, officers seized stocks of 14 vials of TERMIVA Injections and 4 vials of TERMIN Injections (Mephenteramine Sulphate Injections IP 30 mg/ml) from the possession of Bariga Akash.
Officers of Drugs Control Administration viz. Smt. D. Swetha Bindu, Drugs Inspector, Gandipet, Sri. K. Anvesh, Drugs Inspector, Shabad, and Sri. G. Ravi Kiran, Drugs Inspector, Rajendranagar among the officers who carried out the raid. The illegal stocking and sale of drugs is a violation of the Drugs and Cosmetics Act, and individuals involved can face imprisonment for up to five years.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751